The Maternal Mental Health Leadership Alliance (MMHLA) has named Ariel Gonzalez, principal, to their Board of Directors. MMHLA is a nonpartisan nonprofit organization dedicated to promoting the mental health of childbearing people in the United States by advocating for mental health during pregnancy and the year following pregnancy with a focus on federal legislation, and by sharing information about these conditions with others in the fields of maternal-child healthcare and mental health. In his role, Ariel will provide leadership to MMHLA as they raise awareness about maternal mental health (MHH) conditions, reducing their stigma and improving health outcomes for mothers and babies. He will draw upon his experience in the mental health and maternal health arenas from his past leadership with the American Psychiatric Association and the March of Dimes.
Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,095 registered lobbying firms in 2020.
Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,139 registered lobbying firms in 2019.
Jennifer Bell, founding partner, provides political context for and strategic insights into “The Biden Administration, the 117 Congress, and What We Might See in Healthcare.”
Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!
In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continue their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition. They also discuss the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.
A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discuss and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.
In part one, Dr. Shulkin and Ms. Bell discuss the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discuss the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.
Chamber Hill Strategies has hired Deema Tarazi as a senior associate. She was previously a lobbyist for March of Dimes and plans to register to lobby in her new role as well, according to the firm.
Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.
Ariel Gonzalez is joining Chamber Hill Strategies as a principal. He most recently was head of government affairs for March of Dimes, and is an AARP alum.
Chamber Hill has hired Ariel Gonzalez as a principal and leading Democrat for the firm. He was most recently senior vice president of public policy and government relations for the March of Dimes.